Back to Authors

Holloway, Robert W.

https://orcid.org/0000-0002-3121-4605

A5032881252 | I4210085997

Mayo Clinic

Florida Hospital Cancer Institute

Citations 2

Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma

JAMA Oncology | June 13, 2019 | Volume: 5 | Issue: 8 | Pages: 1141

10.1001/jamaoncol.2019.1048 | PMID 31194228

TOPACIO/Keynote-162 (NCT02657889): A phase 1/2 study of niraparib + pembrolizumab in patients (pts) with advanced triple-negative breast cancer or recurrent ovarian cancer (ROC)—Results from ROC cohort.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 106-106

10.1200/jco.2018.36.15_suppl.106